These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2472340)
1. Relationship of the effects of interferon on chronic hepatitis B and the induction of 2',5'-oligoadenylate synthetase. Nishiguchi S; Kuroki T; Otani S; Takeda T; Hirota S; Shimizu Y; Nakajima S; Saito S; Shiomi S; Kobayashi K Hepatology; 1989 Jul; 10(1):29-33. PubMed ID: 2472340 [TBL] [Abstract][Full Text] [Related]
2. Serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B. Shindo M; Okuno T; Matsumoto M; Takeda M; Takino T; Sokawa J; Iwata A; Sokawa Y Hepatology; 1988; 8(2):366-70. PubMed ID: 2451634 [TBL] [Abstract][Full Text] [Related]
3. Interferon-associated lymphocyte 2',5'-oligoadenylate synthetase in acute and chronic viral hepatitis. Heathcote J; Kim YI; Yim CK; LeBrocq J; Read SE Hepatology; 1989 Jan; 9(1):105-9. PubMed ID: 2461889 [TBL] [Abstract][Full Text] [Related]
4. Elevated levels of 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during acute exacerbation of chronic hepatitis B. Shindo M; Okuno T; Arai K; Matsumoto M; Takeda M; Takino T; Sokawa Y Hepatology; 1989 May; 9(5):715-9. PubMed ID: 2468593 [TBL] [Abstract][Full Text] [Related]
5. 2',5'-Oligoadenylate synthetase activity in the liver and peripheral blood mononuclear cells of chronic hepatitis patients. Ogawa Y Gastroenterol Jpn; 1988 Jun; 23(3):279-86. PubMed ID: 2456963 [TBL] [Abstract][Full Text] [Related]
6. [Mechanisms of the effect of interferon (IFN) therapy in patients with type B and C chronic hepatitis]. Karino Y Hokkaido Igaku Zasshi; 1993 May; 68(3):297-309. PubMed ID: 7686526 [TBL] [Abstract][Full Text] [Related]
7. Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life. Ikeda T; Lever AM; Thomas HC Hepatology; 1986; 6(5):962-5. PubMed ID: 2428724 [TBL] [Abstract][Full Text] [Related]
8. [2'-5' oligoadenylate synthetase activity in patients with acute viral hepatitis and chronic type B hepatitis, and its clinical significance]. Komiyama T; Akaike M; Satomura K; Okumura H Nihon Ika Daigaku Zasshi; 1991 Jun; 58(3):262-72. PubMed ID: 1715348 [TBL] [Abstract][Full Text] [Related]
9. Indomethacin enhances serum 2'5'-oligoadenylate synthetase in patients with hepatitis B and C virus chronic active hepatitis. Andreone P; Cursaro C; Gramenzi A; Buzzi A; Miniero R; Sprovieri G; Gasbarrini G J Hepatol; 1994 Dec; 21(6):984-8. PubMed ID: 7699263 [TBL] [Abstract][Full Text] [Related]
10. Decreased interferon binding capacity of peripheral blood mononuclear cells during interferon treatment of chronic hepatitis B with special reference to (2'-5') oligoadenylate synthetase activity. Shindo M; Iwata A; Okuno T; Matsumoto M; Takeda M; Arai K; Sokawa Y Gastroenterol Jpn; 1989 Dec; 24(6):670-5. PubMed ID: 2481600 [TBL] [Abstract][Full Text] [Related]
11. Changes in interferon receptors on peripheral blood mononuclear cells from patients with chronic hepatitis B being treated with interferon. Nakajima S; Kuroki T; Shintani M; Kurai O; Takeda T; Nishiguchi S; Shiomi S; Seki S; Kobayashi K Hepatology; 1990 Dec; 12(6):1261-5. PubMed ID: 2147916 [TBL] [Abstract][Full Text] [Related]
12. 2',5'-Oligoadenylate synthetase activity in peripheral blood lymphocytes as a clinical marker in interferon therapy for chronic hepatitis B. Furuta M; Akashi K; Nakamura Y; Matsumoto K; Yamaguchi H; Takamatsu S; Shimizu T J Interferon Res; 1987 Feb; 7(1):111-9. PubMed ID: 3585079 [TBL] [Abstract][Full Text] [Related]
13. Activity of the interferon-induced 2',5'-oligoadenylate synthetase in patients with chronic hepatitis C. Pawlotsky JM; Hovanessian A; Roudot-Thoraval F; Lebon P; Robert N; Bouvier M; Babany G; Duval J; Dhumeaux D J Interferon Cytokine Res; 1995 Oct; 15(10):857-62. PubMed ID: 8564707 [TBL] [Abstract][Full Text] [Related]
14. Effects of interferon on intrahepatic human leukocyte antigens and lymphocyte subsets in patients with chronic hepatitis B and C. Hayata T; Nakano Y; Yoshizawa K; Sodeyama T; Kiyosawa K Hepatology; 1991 Jun; 13(6):1022-8. PubMed ID: 1711000 [TBL] [Abstract][Full Text] [Related]
15. Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: relationship to the antiviral effect of IFN-alpha. Pawlotsky JM; Hovanessian AG; Roudot-Thoraval F; Robert N; Bouvier M; Babany G; Duval J; Dhumeaux D Antimicrob Agents Chemother; 1996 Feb; 40(2):320-4. PubMed ID: 8834873 [TBL] [Abstract][Full Text] [Related]
16. [Changes in serum levels of beta 2-microglobulin, neopterin and 2',5'-oligoadenylate synthase activity during clearance of hepatitis B virus with or without acute phase in transaminases]. Carreño García V; Hernández-Guío C; Bartolomé Nebreda J; Quiroga Estévez JA Rev Esp Enferm Dig; 1993 Mar; 83(3):169-75. PubMed ID: 7683894 [TBL] [Abstract][Full Text] [Related]
17. Activities of 2'-5'oligoadenylate synthetase in peripheral blood mononuclear cells of patients with viral hepatitis, and chronic type B hepatitis during interferon therapy. Sugawara T; Matsushima T; Miyazaki T; Toyota J; Fujii N; Minagawa T Jpn J Med; 1986 May; 25(2):144-8. PubMed ID: 3747259 [TBL] [Abstract][Full Text] [Related]
18. Methods for the determination of the interferon-induced enzyme 2'-5' oligoadenylate synthetase in mononuclear blood cells. Bruchelt G; Beck J; Schilbach-Stückle K; Koscielniak E; Treuner J; Niethammer D J Clin Chem Clin Biochem; 1987 Dec; 25(12):879-88. PubMed ID: 2450958 [TBL] [Abstract][Full Text] [Related]
19. [Activation of the interferon system enzymes by recombinant alpha2-interferon in patients with chronic hepatitis B]. Sokolova TM; Bugaeva NP; Suetina IA; Ershov FI; Ketiladze ES Antibiot Khimioter; 1989 Jun; 34(6):472-5. PubMed ID: 2552947 [TBL] [Abstract][Full Text] [Related]
20. Detection of 2',5' oligoadenylate synthetase activity in acute viral hepatitis with special reference to histologic features in the acute stage. Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M; Kashima K; Sokawa Y Gastroenterol Jpn; 1991 Apr; 26(2):162-9. PubMed ID: 1710193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]